Those who interrupted GLP-1 treatment and subsequently resumed before the end of the three-year trial period experienced less benefit compared to those who stayed on the medication, with longer gaps in treatment corresponding to smaller reductions in cardiovascular risk
Larger, well-designed studies are needed to confirm whether GLP-1 therapies are safe and effective for alcohol and other substance use disorders and to understand who might benefit most and how best to use them
While no supplement can completely prevent this, supporting collagen synthesis through adequate glycine availability gives your skin the building blocks it needs to remodel as your body composition changes
McLean BA, Wong CK, Kabir MG, Drucker DJ
Some metabolic markers improve even more strongly with Retatrutide due to glucagon receptor activity
Let us guide you toward a healthier, more confident version of yourself!